======= CYP1A2 ======= == Gene Information == * **Official Symbol**: CYP1A2 * **Official Name**: cytochrome P450 family 1 subfamily A member 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1544|1544]] * **UniProt**: [[https://www.uniprot.org/uniprot/P05177|P05177]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CYP1A2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CYP1A2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/124060|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Most active in catalyzing 2-hydroxylation. Caffeine is metabolized primarily by cytochrome CYP1A2 in the liver through an initial N3-demethylation. Also acts in the metabolism of aflatoxin B1 and acetaminophen. Participates in the bioactivation of carcinogenic aromatic and heterocyclic amines. Catalizes the N-hydroxylation of heterocyclic amines and the O- deethylation of phenacetin. {ECO:0000269|PubMed:14725854}. |p450| |oxidative deethylation| |dibenzo-p-dioxin metabolic process| |estrogen 2-hydroxylase activity| |caffeine oxidase activity| |toxin biosynthetic process| |monoterpenoid metabolic process| |demethylase activity| |alkaloid metabolic process| |hydrogen peroxide biosynthetic process| |estrogen 16-alpha-hydroxylase activity| |omega-hydroxylase P450 pathway| |antibiotic biosynthetic process| |secondary metabolite biosynthetic process| |oxidative demethylation| |epoxygenase P450 pathway| |toxin metabolic process| |reactive oxygen species biosynthetic process| |response to immobilization stress| |steroid catabolic process| |exogenous drug catabolic process| |cellular response to copper ion| |oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen| |long-chain fatty acid biosynthetic process| |monooxygenase activity| |estrogen metabolic process| |porphyrin-containing compound metabolic process| |cellular response to cadmium ion| |hydrogen peroxide metabolic process| |retinol metabolic process| |response to copper ion| |secondary metabolic process| |arachidonic acid metabolic process| |tetrapyrrole metabolic process| |demethylation| |response to cadmium ion| |electron transfer activity| |primary alcohol metabolic process| |post-embryonic development| |retinoid metabolic process| |antibiotic metabolic process| |unsaturated fatty acid metabolic process| |diterpenoid metabolic process| |icosanoid metabolic process| |reactive oxygen species metabolic process| |long-chain fatty acid metabolic process| |oxidoreductase activity| |fatty acid biosynthetic process| |terpenoid metabolic process| |cellular hormone metabolic process| |xenobiotic metabolic process| |iron ion binding| |response to estradiol| |isoprenoid metabolic process| |heme binding| |drug catabolic process| |fatty acid derivative metabolic process| |cellular respiration| |lung development| |respiratory tube development| |electron transport chain| |monocarboxylic acid biosynthetic process| |cellular response to xenobiotic stimulus| |cellular response to metal ion| |respiratory system development| |hormone metabolic process| |cofactor biosynthetic process| |cellular response to inorganic substance| |energy derivation by oxidation of organic compounds| |steroid metabolic process| |lipid catabolic process| |response to xenobiotic stimulus| |carboxylic acid biosynthetic process| |organic acid biosynthetic process| |methylation| |response to lipopolysaccharide| |alcohol metabolic process| |fatty acid metabolic process| |response to molecule of bacterial origin| |enzyme binding| |response to metal ion| |generation of precursor metabolites and energy| |cofactor metabolic process| |organic hydroxy compound metabolic process| |organic cyclic compound catabolic process| |drug metabolic process| |monocarboxylic acid metabolic process| |response to inorganic substance| |regulation of hormone levels| |lipid biosynthetic process| |small molecule biosynthetic process| |intracellular membrane-bounded organelle| |response to bacterium| |tube development| |response to lipid| |response to hormone| |carboxylic acid metabolic process| |response to organic cyclic compound| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |oxidation-reduction process| |oxoacid metabolic process| |response to drug| |organic acid metabolic process| |lipid metabolic process| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |response to endogenous stimulus| |response to oxygen-containing compound| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp170|Metformin 100 to 150μM on day4 R04 exp170]]|1.73| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.504| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2812 * **Expression level (log2 read counts)**: 2.81 {{:chemogenomics:nalm6 dist.png?nolink |}}